fda pulling semaglutide ๐จ Moves to Shut Down Mass-Market Compounded GLP-1s The FDA is taking action to restrict widely marketed, nonโFDA-approved compounded GLP-1 products, citing concerns over safety, quality, and misleading claims. As demand Hims & Hers stock crashes
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 11 - Aug 16


























